Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

has now listed Novo Nordisk’s blockbuster diabetes and obesity medications Wegovy and Ozempic as “available.” Semaglutide ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...